Company: RGBP
Filing Date: 2025-12-05
Form Type: 253G1
Source: 0001493152-25-026350
Chunk: 109

Company: Regen BioPharma Inc
Filing Date: 2025-12-05
Form: 253G1
Chunk 109
---
 bears simple interest at a rate of 10% per annum.

$4,700 lent to the Company by Zander Therapeutics, Inc. is due and payable on October 15 2025 and bears simple interest at a rate of 10% per annum.

$4,500 lent to the Company by Zander Therapeutics, Inc. is due and payable on October 23 2025 and bears simple interest at a rate of 10% per annum.

Zander Therapeutics, Inc. and the Company are under common control.

During the quarter ended December 31, 2024 BST Partners lent the Company $46,599

During the quarter ended March 31, 2025 BST Partners lent the Company $40,616.

BST Partners and the Company are under common control.

<div align='center'>83

REGEN BIOPHARMA , INC.

CONDENSED CONSOLIDATED BALANCE SHEETS</div>

| ASSETS:                                                                                                                    
 Current                                                                                                                    
 Assets                                                                                                                     |     | December 
 31,      
 2024     | (Unaudited) |   |     | September 
 30,       
 2024      |         (As 
   Restated) |   |
|:---------------------------------------------------------------------------------------------------------------------------|:----|:---------|------------:|:--|:----|:----------|------------:|:--|
| Cash                                                                                                                       |     | $        |         135 |   |     |           |         716 |   |
| Accounts                                                                                                                   
 receivable, related party                                                                                                  |     |          |     122,298 |   |     |           |      94,873 |   |
| Prepaid                                                                                                                    
 expenses                                                                                                                   |     |          |      51,250 |   |     |           |      47,762 |   |
| Total                                                                                                                      
 Current Assets                                                                                                             |     |          |     173,683 |   |     |           |     143,351 |   |
| Other                                                                                                                      
 Assets                                                                                                                     |     |          |             |   |     |           |             |   |
| Investment                                                                                                                 
 securities, related party                                                                                                  |     |          |      17,733 |   |     |           |      17,733 |   |
| Total                                                                                                                      
 Other Assets                                                                                                               |     |          |      17,733 |   |     |           |      17,733 |   |
| TOTAL